Dr. Kemeny on Liver-Directed Therapy for Metastatic CRC
Nancy E. Kemeny, MD
Nancy E. Kemeny, MD, a medical oncologist at Memorial Sloan Kettering Cancer Institute, discusses liver-directed therapies for patients with metastatic colorectal cancer (CRC).
Although there are new drugs for the treatment of CRC, there are still many patients who die from metastatic disease, explains Kemeny. According to Kemeny, 70% of patients with metastatic disease will have liver metastases.
It is important to direct chemotherapy into the liver to help those patients, says Kemeny. Giving drugs straight to the liver either in first-line or beyond could achieve better results.